Bradley Radoff and Jumana Capital disclosed a joint 7.6% stake in Genesco, the Nashville-based footwear retailer, in a Schedule 13D filed Wednesday. The coalition now controls approximately 870,000 shares worth roughly $57 million at current trading levels. Genesco operates 1,425 stores across Journeys, Johnston & Murphy, and Schuh, generating $2.3 billion in trailing revenue against a $760 million market capitalization.

The filing marks Radoff's third disclosed retail position since mid-2023, following stakes in Destination XL Group and Tilly's. Genesco shares traded up 8.2% on volume 240% above the thirty-day average within two hours of the disclosure. The company reported same-store sales down 2.1% in its most recent quarter, with operating margin compression of 110 basis points year-over-year. Management has attributed the softness to promotional intensity in mall-based footwear and a $43 million inventory writedown tied to shifting consumer preference away from athletic-casual hybrids. Free cash flow for the trailing twelve months stands at $68 million, barely covering the $64 million in lease obligations coming due over the next eighteen months.

Radoff's timing follows a 34% drawdown in Genesco shares from their April 2024 peak, bringing the stock to 0.32x trailing sales and 5.8x forward earnings estimates. The company's balance sheet carries $287 million in net debt, but owns its Johnston & Murphy manufacturing facilities outright and holds $140 million in unencumbered real estate across distribution centers in Tennessee and Kentucky. Jumana Capital, a Dallas-based fund with $380 million in disclosed equity positions, has historically favored turnaround situations in specialty retail where asset values exceed enterprise value by 30% or more. That spread currently sits at 41% for Genesco, assuming midpoint appraisals on owned real estate and a 15% discount on leasehold improvements. The coalition's 13D does not yet specify board representation or strategic demands, but the filing language—"to engage in discussions with management regarding strategic alternatives"—suggests more than passive observation.

Operators should track two near-term catalysts. First, Genesco's fiscal Q4 earnings on March 20th will reveal whether the $12 million cost-reduction program announced in November is hitting targets, and whether Journeys same-store sales have stabilized after six consecutive quarters of decline. Second, Radoff's prior campaigns at Destination XL and Tilly's both resulted in board seats within 90 days of initial disclosure, often preceded by informal settlement talks. Any 13D amendment adding nominees or detailing capital-allocation critiques would likely surface before the April 15th proxy deadline. The Street will also watch whether Jumana adds to its position; the fund has historically accumulated to 12-14% before formalizing governance asks.

Genesco's annual meeting is scheduled for June 12th. The company has not yet filed its preliminary proxy, meaning the nomination window remains open through early April under Tennessee corporate law.